Celine Halioua

Celine Halioua⁠

Loyal

Founder & CEO at Loyal

About

I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.

Experiences

  1. Founder & CEO at LoyalTaking the first dog lifespan drug through the FDA

    We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.

  2. Chief of Staff at The Longevity FundWorked on human aging in venture, then went dogs first

    As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.

  3. SwedenSpent a year in Sweden at 21 and almost didn't leave

    I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.

  4. DPhil in Paediatrics (incomplete) at University of OxfordFlew back and forth to avoid dropping out of Oxford

    I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.

  5. Researcher: Neuro-oncology at Sanford Burnham PrebysTried to replace Parkinson's neurons, then chose prevention

    Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.

  6. Author at How to Build a BiotechWrote a guide for anyone curious about starting a biotech

    It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.

  7. Early lifeGrew up in Austin with 15 cats and rescued squirrels

    We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.

Follow Celine for more...

XInstagramLinkedInWebsiteWebsite

© 2026 Delphi · Terms · Privacy

Celine Halioua

Celine Halioua⁠

Loyal

Founder & CEO at Loyal

About

I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.

Experiences

  1. Founder & CEO at LoyalTaking the first dog lifespan drug through the FDA

    We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.

  2. Chief of Staff at The Longevity FundWorked on human aging in venture, then went dogs first

    As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.

  3. SwedenSpent a year in Sweden at 21 and almost didn't leave

    I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.

  4. DPhil in Paediatrics (incomplete) at University of OxfordFlew back and forth to avoid dropping out of Oxford

    I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.

  5. Researcher: Neuro-oncology at Sanford Burnham PrebysTried to replace Parkinson's neurons, then chose prevention

    Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.

  6. Author at How to Build a BiotechWrote a guide for anyone curious about starting a biotech

    It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.

  7. Early lifeGrew up in Austin with 15 cats and rescued squirrels

    We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.

Follow Celine for more...

XInstagramLinkedInWebsiteWebsite

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.